Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)

NCT03875651 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03875651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03875651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
May 9, 2019
Completion date
November 28, 2023
Enrollment
100 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, coronary artery disease, heart diseases, coronary